A randomized, double-blind study comparing the efficacy and safety of Trazodone OAD and venlafaxine XR in the treatment of patients with Major Depressive Disorder.
Phase of Trial: Phase III
Latest Information Update: 15 Jun 2016
Price : $35 *
At a glance
- Drugs Trazodone (Primary) ; Venlafaxine
- Indications Major depressive disorder
- Focus Registrational; Therapeutic Use
- Sponsors Angelini Group
- 29 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2012 New trial record